Unlocking the potential of β-1,3-xylooligosaccharides from Caulerpa lentillifera: structural characterization, antioxidative and anti-osteoarthritis applications

Abstract

Abstract Background β-1,3-Xylooligosaccharides (XOS-3) extracted from Caulerpa lentillifera have shown potential antioxidative and anti-tumor properties, but research on their biological activities, particularly their anti-osteoarthritis effects, is still in early stages. Results XOS-3 were produced by eco-friendly enzymatic hydrolysis, displaying a semi-crystalline structure with predominant xylose, xylobiose, xylotriose, and xylotetraose components which were confirmed by IC, SEM, FT-IR, and XRD analysis. Compared with β-1,4-xylooligosaccharides, XOS-3 had stronger antioxidant properties, and the scavenging rate of O2 •− and DPPH• radicals was 82.31% and 58.44% at 2.0 mg/mL respectively. In vitro studies, XOS-3 significantly improved cell viability in IL-1β-induced rat chondrocytes from 43.41 to 73.5% at 100 μg/mL, demonstrating anti-inflammatory and cartilage-protective effects by modulating MMP13 and COL2A1 expression. Conclusions The study displayed the potential antioxidative and anti-osteoarthritis effects of XOS-3, offering new visuals for the development of marine polysaccharides in the treatment of osteoarthritis. Graphical Abstract

Keywords

• β-1,3-xylan
• β-1,3-xylooligosaccharides
• Antioxidant
• Osteoarthritis
• Enzymatic hydrolysis